Maria Ashioti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria Ashioti has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Andrew S. Lowe
MRC Centre for Developmental Neurobiology, King's College London, Guy's Hospital Campus, London SE1 1UL, United Kingdom
2 shared publications - Michel Modo
Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
2 shared publications - Steve Charles Rees Williams
Department of Neuroimaging Institute of Psychiatry, Psychology and Neuroscience King's College London London UK
2 shared publications - Andrew C. McCreary
Solvay Pharmaceuticals Research Laboratories, van Houtenlaan 36, 1381 CP, Weesp, The Netherlands
1 shared publication John S. Beech
Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK
1 shared publication- John S. Beech
Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK
1 shared publication
Latest Publications
- Open Access
- 16 July 2009
- Published by Springer Nature in BMC Neuroscience
- Vol. 10 (1) , 82
Neither in vivo MRI nor behavioural assessment indicate therapeutic efficacy for a novel 5HT1A agonist in rat models of ischaemic stroke
5HT1A agonists have previously been shown to promote recovery in animal models of stroke using ex vivo outcome measures which have raised the hopes for a potential clinical implementation. The purpose of this study was to evaluate the potential neuroprotective properties of a novel 5HT1A agonist DU123015 in 2 different models of transient focal ischaemic stroke of varying severities using both in vivo neuroimaging and behavioural techniques as primary outcome measures. For these studies, the NMDA receptor antagonist MK-801 was also utilized as a positive control to further assess the effectiveness of the stroke models and techniques used.
- 16 July 2009
- Published by Springer Nature in BMC Neuroscience
- Vol. 10 (1) , 82
Open AccessNeither in vivo MRI nor behavioural assessment indicate therapeutic efficacy for a novel 5HT1A agonist in rat models of ischaemic stroke
5HT1A agonists have previously been shown to promote recovery in animal models of stroke using ex vivo outcome measures which have raised the hopes for a potential clinical implementation. The purpose of this study was to evaluate the potential neuroprotective properties of a novel 5HT1A agonist DU123015 in 2 different models of transient focal ischaemic stroke of varying severities using both in vivo neuroimaging and behavioural techniques as primary outcome measures. For these studies, the NMDA receptor antagonist MK-801 was also utilized as a positive control to further assess the effectiveness of the stroke models and techniques used.
- 1 May 2007
- Published by Elsevier in Brain Research
- Vol. 1145, 177-189
Multi-modal characterisation of the neocortical clip model of focal cerebral ischaemia by MRI, behaviour and immunohistochemistry
- 1 May 2007
- Published by Elsevier in Brain Research
- Vol. 1145, 177-189
Multi-modal characterisation of the neocortical clip model of focal cerebral ischaemia by MRI, behaviour and immunohistochemistry